80
Participants
Start Date
July 1, 2022
Primary Completion Date
January 1, 2026
Study Completion Date
July 1, 2027
Medication or psychosocial treatment
Youth included in this naturalistic study will be offered medication management from study psychiatrists. The study's Network Oversight Committee, consisting of PI psychiatrists and consultants, has created guidelines on best practice medications, dosing, and adjustments for the study. The Network Oversight Committee will also offer ongoing consultation to study psychiatrists. The treating physician will take these guidelines and recommendations under consideration but will use clinical judgment and have the final say, in consultation with the parents and child, as to what treatments are prescribed. While psychosocial interventions are of interest as a predictor of outcomes, no universal psychotherapy or other psychosocial treatment will be provided by sites. There is no limitation on participant enrollment in psychosocial treatments. Investigators and their clinical partners may offer these interventions based on clinical judgment and availability.
ENROLLING_BY_INVITATION
University of Pittsburgh Child and Adolescent Bipolar Spectrum Services Clinic (CABS), Pittsburgh
ENROLLING_BY_INVITATION
Virginia Commonwealth University Medical Center, Richmond
ENROLLING_BY_INVITATION
University of Colorado Anschutz Medical Campus, Helen and Arthur E. Johnson Depression Center, Aurora
RECRUITING
University of California, Los Angeles, Max Gray Child and Adolescent Mood Disorders Program (CHAMP), Los Angeles
Collaborators (1)
University of Pittsburgh
OTHER
Virginia Commonwealth University
OTHER
University of Colorado, Denver
OTHER
Milken Institute
OTHER
Baszucki Brain Research Fund
OTHER
University of California, Los Angeles
OTHER